Wellcome Leap is not the Wellcome Trust. The two names are easy to conflate — Leap was created by the Trust and carries its name — but they are legally separate organizations with fundamentally different funding models, application mechanics, and grant-management implications for a research administrator. This guide is specifically about Wellcome Leap: what it is, how its DARPA-style, milestone-driven program model works, and exactly how it diverges from standard Wellcome Trust grant-making. For Wellcome Trust’s own scheme structure, see CASRAI’s Wellcome Trust Funding guide, and for two of its individual award programs, see the Wellcome Trust Discovery Award and Wellcome Career Development Award guides.
What Wellcome Leap Is
Wellcome Leap is a US-based 501(c)(3) nonprofit organization launched in May 2020 by the Wellcome Trust, the UK charitable foundation, with an initial commitment reported at US$300 million; a further US$335 million was reported in February 2022, bringing total reported funding to roughly US$635 million. Leap operates with its own independent board and its own leadership — its founding CEO, Regina E. Dugan, previously directed the U.S. Defense Advanced Research Projects Agency (DARPA), and its chairman, Jay Flatley, was formerly CEO of Illumina. Although the Wellcome Trust created and funded Leap, Leap is a legally and operationally separate entity, not a division, program, or scheme of the Trust itself.
Leap describes its own mission as building “bold, unconventional” health-research programs and funding them at scale, aiming for breakthroughs in human health that a conventional, single-investigator grant cycle is not structured to deliver quickly. Its model is explicitly adapted from DARPA’s approach to defense research — program-manager-led, goal-directed, and organized around time-boxed, milestone-gated funding rather than open-ended investigator-led inquiry.
The DARPA-Style, Milestone-Driven Funding Model
This is the structural core of what separates Leap from a conventional research funder, including the Wellcome Trust. Rather than issuing standing grant schemes that any eligible researcher can apply to on a recurring cycle, Leap designs individual, named programs around a specific health challenge (recent and current program areas have included fetal development monitoring, heavy menstrual bleeding diagnosis, coronary microvascular disease, antibiotic resistance, and Alzheimer’s risk reduction, among others). Each program is:
- Goal-directed, not open-ended. A Leap program manager defines a specific, ambitious target outcome up front — closer to a defense-research “moonshot” brief than an open call for investigator-initiated proposals.
- Milestone-gated. Funded teams must hit defined technical milestones at set checkpoints to continue receiving funding through the program; a program’s structure explicitly builds in the option to redirect or discontinue funding for underperforming teams rather than committing the full award up front regardless of progress.
- Time-boxed around three-year phases. Individual Leap programs are built and run as three-year, milestone-driven efforts, even where the underlying health challenge is framed on a longer, roughly five-to-ten-year horizon to reach real-world impact.
- Multi-team and multi-institutional by design. A single Leap program typically funds several teams working in parallel toward the same milestone targets — a portfolio approach to a defined problem, not a single principal investigator’s individual research agenda.
- Run from participants’ home institutions. Unlike a defense-research model built around a central government facility, Leap-funded researchers continue to work from their existing home institutions, with Leap coordinating the program centrally.
Leap also states it uses a standardized funding agreement intended to reduce the administrative delay typically associated with starting a sponsored project — a deliberate departure from the individually negotiated grant agreements and institutional overhead structures research administrators are used to handling under a standard funder relationship.
How Wellcome Trust’s Model Differs
The Wellcome Trust, by contrast, is an endowment-funded UK charitable foundation (see CASRAI’s Wellcome Trust Funding guide for the full structure) that runs standing, recurring grant schemes organized around named awards — the Discovery Award, Early-Career Award, and Career Development Award among them — open to eligible applicants on a defined cycle, evaluated primarily on the strength of an investigator’s own proposed research question. A Trust award is typically held by a single lead applicant or small named team at one host institution, funded for a duration set by the scheme (commonly five to eight years depending on career stage), and assessed against the applicant’s own research plan rather than against externally defined interim milestones set by a program manager.
Wellcome Leap vs. Wellcome Trust: Side-by-Side
| Dimension | Wellcome Leap | Wellcome Trust |
|---|---|---|
| Legal structure | Separate US 501(c)(3) nonprofit, independently governed, established by the Wellcome Trust in 2020 | UK charitable foundation, endowment-funded, founded 1936 |
| Funding model | Program-manager-designed “moonshot” programs targeting a defined health outcome | Standing grant schemes responding to investigator-initiated proposals |
| Selection basis | Teams selected and funded against a program’s predefined target and milestones | Applications assessed on the merit of the applicant’s own proposed research question |
| Award structure | Milestone-gated, multi-team, funding can be redirected or discontinued based on progress against checkpoints | Fixed-term award to a named lead applicant/team, funded for the scheme’s set duration once granted |
| Typical timeframe | Three-year, milestone-driven program phases, aimed at a roughly 5–10 year path to real-world impact | Scheme-dependent, commonly five to eight years depending on career stage |
| Who applies | Teams responding to a specific program’s defined challenge and call | Individual researchers/PIs applying to an open, recurring scheme |
| Administrative model | States it uses a standardized funding agreement intended to reduce start-up delay | Individually negotiated grant terms consistent with a standard research-grant agreement |
Why the Distinction Matters for Research Administrators
Confusing the two organizations at the pre-award stage risks real mistakes: a proposal, budget structure, or eligibility check built for a standard Wellcome Trust scheme will not map cleanly onto a Wellcome Leap program, and vice versa. A research administrator supporting a PI who is exploring either funder should confirm, before anything else, which organization a given opportunity actually belongs to — the branding overlap (“Wellcome” in both names) is exactly the kind of collision that leads to a wrong-template submission or a missed milestone-reporting obligation later. Practical implications include:
- Leap’s milestone-gated structure means post-award administration should build in checkpoint reporting against externally defined technical milestones, not just a standard progress-report cadence.
- Because Leap programs fund multiple teams against one shared target, an institution may be one of several subrecipients or partner sites on a single program rather than the sole recipient of a standard investigator grant — worth confirming the award structure (prime recipient vs. team member) early.
- Leap’s standardized funding agreement, if used for a given program, may differ materially from an institution’s usual sponsored-research agreement template and is worth routing through the same institutional review a new funder relationship would normally get.
- Because Leap runs individual, time-limited program calls tied to specific health challenges rather than a recurring standing scheme, eligibility and open-call windows should be checked directly against Leap’s current program list rather than assumed to follow a Wellcome Trust-style annual or biannual cycle.
Neither organization’s specific per-program or per-award dollar figures should be assumed current from this page — both publish and periodically update these directly; verify against wellcomeleap.org or wellcome.org respectively before citing a specific figure in a proposal or institutional communication.
Frequently Asked Questions
Is Wellcome Leap the same organization as the Wellcome Trust?
No. Wellcome Leap is a separate, independently governed US 501(c)(3) nonprofit that the Wellcome Trust established and initially funded in 2020. It has its own board, its own leadership, and its own funding model — it is not a scheme, division, or program of the Wellcome Trust.
Why does Wellcome Leap use a DARPA-style model?
Leap’s founding CEO, Regina E. Dugan, previously directed DARPA, and Leap explicitly built its program model — goal-directed, milestone-gated, time-boxed funding aimed at a specific outcome — on that approach, applying it to human-health challenges rather than defense research.
How long do Wellcome Leap programs run?
Individual Leap programs are structured as three-year, milestone-driven phases, though the underlying health challenge a program targets is often framed against a longer, roughly five-to-ten-year horizon for reaching real-world impact.
Can I apply to Wellcome Leap the same way I’d apply for a Wellcome Trust award?
Not in the same way. A Wellcome Trust award responds to an open, recurring scheme evaluated on the applicant’s own proposed research question. A Wellcome Leap program instead issues its own call tied to a specific, program-manager-defined challenge and target milestones, and teams apply against that specific program’s call rather than a standing, general scheme.
Does a Wellcome Leap award go through the same institutional grant-agreement process as a Wellcome Trust award?
Not necessarily. Leap states it uses a standardized funding agreement designed to reduce administrative start-up delay, which may differ from the sponsored-research agreement template an institution typically negotiates with the Wellcome Trust or other standard funders — confirm the specific agreement terms with your institution’s sponsored-programs office before assuming standard templates apply.
